r version 4 4 2 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
r version 4 4 2
R Version 4 4 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 2476 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+version+4+4+2/STATA+4%2E0/pm41928342-165-10-6
Average 99 stars, based on 2476 article reviews
R Version 4 4 2, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 2476 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/r+version+4+4+2/STATA+4%2E0/pm41928342-165-10-6
Average 99 stars, based on 2476 article reviews
r version 4 4 2 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: Cancer Incidence in Women After Medically Assisted Reproduction Article Snippet: Analyses were performed April 2024 to November 2024 using a combination of SAS version 9.4 (SAS Institute), R version 4.4.2 (R Project for Statistical Computing), and Article Title: Cancer Incidence in Women After Medically Assisted Reproduction. Article Snippet: The original analysis plan is available online.26 Analyses were performed April 2024 to November 2024 using a combination of SAS version 9.4 (SAS Institute), R version 4.4.2 (R Project for Statistical Computing), and Stata version 19 ( Article Title: Socioeconomic status, healthy lifestyle, and the risk of frailty: Evidence from two prospective cohort studies. Article Snippet: All data analyses were performed using Article Title: The stability of pain phenotypes in people with hand osteoarthritis – results from the NOR-HAND study Article Snippet: The LTAs were performed with R version 4.4.2 ( https://www.R-project.org/ ) , while Article Title: Associations between smart health device use and depressive symptoms in older adults from the China longitudinal aging social survey. Article Snippet: All statistical procedures were executed using Article Title: Comparative Effectiveness of Oral Anticoagulants and Home Time After Venous Thromboembolism in Frail and Non-Frail Older Adults. Article Snippet: In this retrospective cohort of 18 066 Medicare feeforservice beneficiaries ≥ 65 years with acute VTE (2015–2019), we compared apixaban, rivaroxaban, and warfarin using propensity score (PS) overlap weighting and intentiontotreat analyses across total, nonfrail, and frail strata defined by a claimsbased frailty index.. After PS weighting (all SMDs < 0.10), apixaban versus warfarin was associated with a lower 1year composite of recurrent VTE or death in the total population (189.1 versus 216.1 per 1000 PY; HR 0.86, 95% CI 0.77–0.96), with benefit evident in nonfrail patients (114.5 versus 143.6; HR 0.78, 0.66–0.92) and attenuated in frail patients (330.9 versus 349.9; HR 0.93, 0.82–1.07).. Recurrent VTE rates favored apixaban but were not statistically significant overall (40.5 versus 54.8; HR 0.86, 0.68–1.08). Article Title: Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials Article Snippet: All statistical analyses were performed using Software:Article Title: Predictors of employment attrition in Lebanon during multifaceted crises: The role of chronic diseases – a national cross-sectional study Article Snippet: .. All analyses were conducted using Stata/SE statistical software version 18 ( |